Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$24.67M$24.67Mderived+11.6% vs Q4 2023 Net Income-$756.00K-$756.00KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,631,000+26.5% Operating Incomederived-$519,000N/M Operating Cash Flowderived$865,000N/M Free Cash Flowderived$470,000N/M Margins · derivedGross margin14.7%+1.7 pt vs Q4 2023
Operating margin-2.1%+0.4 pt vs Q4 2023
Net margin-3.1%+3.8 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 20, 2025 · 79 d after period end